Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Current Leases: 2023-2024

Historic Current Leases for Contineum Therapeutics (CTNM) over the last 2 years, with Dec 2024 value amounting to $1.5 million.

  • Contineum Therapeutics' Current Leases rose 141.73% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 141.73%. This contributed to the annual value of $1.5 million for FY2024, which is 212.93% up from last year.
  • Per Contineum Therapeutics' latest filing, its Current Leases stood at $1.5 million for FY2024, which was up 212.93% from $464,000 recorded in FY2023.
  • In the past 5 years, Contineum Therapeutics' Current Leases registered a high of $1.5 million during FY2024, and its lowest value of $464,000 during FY2023.
  • For the 2-year period, Contineum Therapeutics' Current Leases averaged around $958,000, with its median value being $958,000 (2023).
  • Data for Contineum Therapeutics' Current Leases shows a peak YoY surged of 212.93% (in 2024) over the last 5 years.
  • Over the past 2 years, Contineum Therapeutics' Current Leases (Yearly) stood at $464,000 in 2023, then spiked by 212.93% to $1.5 million in 2024.